Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Clare

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
American Heart Journal|May 28, 2013
Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non-ST-segment elevation acute coronary syndromeRoberto R Giraldez, Robert M Clare, Renato D Lopes, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 10, 2021
Predicting major adverse limb events in individuals with type 2 diabetes: Insights from the EXSCEL trialE Hope Weissler, Robert M Clare, Yuliya Lokhnygina, et al.
Journal of the American Heart Association|February 13, 2018
Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure)Ankeet S Bhatt, Lauren B Cooper, Andrew P Ambrosy, et al.
The American Journal of Medicine|August 21, 2016
Impact of Non-Infarct-Related Artery Disease on Infarct Size and Outcomes (from the CRISP-AMI Trial)Rohan Shah, Robert M Clare, Karen Chiswell, et al.
JACC. Advances|October 28, 2025
Traditional and HIV-Specific Risk Factors Associated With Atrial Fibrillation Among Underrepresented Minority Groups With HIVElizabeth A Kobe, Robert M Clare, Karen Chiswell, et al.
Journal of the American Heart Association|March 7, 2025
Association of Cardiologist Clinic Visits With Cardiovascular Primary Prevention Outcomes Among People With HIV From Underrepresented Racial and Ethnic Groups in the Southern United StatesMatthew S Durstenfeld, C Larry Hill, Robert M Clare, et al.
Journal of the American Heart Association|December 12, 2018
Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER TrialLeo Ungar, Robert M Clare, Fatima Rodriguez, et al.
European Heart Journal. Acute Cardiovascular Care|February 21, 2016
Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trialRalf E Harskamp, Robert M Clare, Giuseppe Ambrosio, et al.
American Heart Journal|August 10, 2016
Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trialAxel Åkerblom, Robert M Clare, Yuliya Lokhnygina, et al.
American Heart Journal|June 19, 2018
Discharge timing and outcomes after uncomplicated non-ST-segment elevation acute myocardial infarctionJennifer A Rymer, Michael W Tempelhof, Robert M Clare, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
American Heart Journal|May 28, 2013
Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non-ST-segment elevation acute coronary syndromeRoberto R Giraldez, Robert M Clare, Renato D Lopes, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 10, 2021
Predicting major adverse limb events in individuals with type 2 diabetes: Insights from the EXSCEL trialE Hope Weissler, Robert M Clare, Yuliya Lokhnygina, et al.
Journal of the American Heart Association|February 13, 2018
Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure)Ankeet S Bhatt, Lauren B Cooper, Andrew P Ambrosy, et al.
The American Journal of Medicine|August 21, 2016
Impact of Non-Infarct-Related Artery Disease on Infarct Size and Outcomes (from the CRISP-AMI Trial)Rohan Shah, Robert M Clare, Karen Chiswell, et al.
JACC. Advances|October 28, 2025
Traditional and HIV-Specific Risk Factors Associated With Atrial Fibrillation Among Underrepresented Minority Groups With HIVElizabeth A Kobe, Robert M Clare, Karen Chiswell, et al.
Journal of the American Heart Association|March 7, 2025
Association of Cardiologist Clinic Visits With Cardiovascular Primary Prevention Outcomes Among People With HIV From Underrepresented Racial and Ethnic Groups in the Southern United StatesMatthew S Durstenfeld, C Larry Hill, Robert M Clare, et al.
Journal of the American Heart Association|December 12, 2018
Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER TrialLeo Ungar, Robert M Clare, Fatima Rodriguez, et al.
European Heart Journal. Acute Cardiovascular Care|February 21, 2016
Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trialRalf E Harskamp, Robert M Clare, Giuseppe Ambrosio, et al.
American Heart Journal|August 10, 2016
Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trialAxel Åkerblom, Robert M Clare, Yuliya Lokhnygina, et al.
American Heart Journal|June 19, 2018
Discharge timing and outcomes after uncomplicated non-ST-segment elevation acute myocardial infarctionJennifer A Rymer, Michael W Tempelhof, Robert M Clare, et al.
Pageof 6